Operator

Thank you for standing by, and welcome to the MediPharm Labs conference call to discuss the company's 2026 Q1 results. Our speaker on today's call is Greg Hunter, Interim CEO and Chief Financial Officer. [Operator Instructions] The conference is being recorded. [Operator Instructions] The information during this call should be considered together with the more detailed information, disclosure, financial data and statements available on the company's website and on the SEDAR+ profile at sedar+.ca. As set out on the webcast slide, I would like to note that remarks during this earnings call may contain forward-looking information and forward-looking statements within the meaning of applicable securities laws. This includes, without limitation, statements about MediPharm Labs and its current and future plans, expectations, intentions, financial results, operations, levels of activity, performance, goals or achievements and other future events, trends, profitability, business growth or developments.

All statements other than statements of historical fact are forward-looking statements. The statements made are based on the company's current expectations, estimates and beliefs as of today's date. The company's remarks may also contain references to certain non-IFRS financial measures, including adjusted EBITDA. These measures do not have any standardized meaning according to International Financial Reporting Standards, or IFRS, and therefore, may not be comparable to similar measures presented by other companies. Please review the company's most recent disclosure materials filed on SEDAR+ for the risks associated with forward-looking information and the use of non-IFRS financial measures, including the section titled Reconciliation of non-IFRS measures in the company's most recent MD&A available on SEDAR+. Please note that all dollar amounts mentioned in today's call are in Canadian dollars unless otherwise noted.